Please login to the form below
5
Revenue 2017Merck & Co.
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck & Co.'s 2013 sales performance.
Gilead shells out $375m for immuno-oncology deal with Arcus
The format is similar however, with Gilead securing opt-in co-development and co-marketing rights to Arcus’ small-molecule and antibody-based cancer immunotherapies. ... Co/MSD’s Keytruda (pembrolizumab) and Bristol-Myers Squibb’s Opdivo (nivolumab)
Merck buys Themis as part of drive for COVID-19 drugs and vaccines
Merck &Co/MSD has been conspicuous by its absence from the industry-wide effort to develop coronavirus therapies, but has now unveiled a broad effort across drugs and vaccines. ... Merck – known as MSD outside North America – has been working with
FDA backs BMS’ Opdivo/Yervoy in first-line NSCLC
BMS’ decision to combine Opdivo with Yervoy has allowed the company to carve a space within the NSCLC market, although it will face intense completion from Merck &Co/MSD’s rival ... Merck’s position in the NSCLC market has fostered immense growth,
Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
It is being developed in a strategic partnership with Merck &Co/MSD, formed in 2017, to maximise the potential of PARP and MEK inhibitors.
NICE approves Roche’s Tecentriq in TNBC after revising deal
Merck &Co/MSD’s rival checkpoint inhibitor Keytruda (pembrolizumab) has not shown the same level of efficacy in TNBC, although it has shown promise when used prior to surgery in women
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Regeneron says antibody for COVID-19 could be ready this year
- Biogen delays filing of Alzheimer’s drug, which hits its share price
- Novartis to test canakinumab for COVID-19, as IL-6 trial disappoints
- AZ secures capacity for one billion coronavirus vaccine doses
- UK clears NHS use of Gilead’s remdesivir for COVID-19 patients
- NICE approves Roche’s Tecentriq in TNBC after revising deal
- INFOGRAPHIC 02: The Importance of clinical study websites
- Courageous Conversations ep.8: 10 Tips to Create Company Culture in a Virtual World
- Impetus Digital Fireside Chat with Eddie Power from Pfizer
- Impetus Digital Fireside Chat with Deloitte Europe: The Future of Learning
- Working with, Advocating for, and Empowering Patients
- The concordance conundrum: the value of improving patient experience
PMHub
HAVAS Just::
HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....
Latest intelligence
- INFOGRAPHIC 02: The Importance of clinical study websites
- Here’s a infographic of why clinical study websites are important to patient recruitment and retention strategies…...
- Working with, Advocating for, and Empowering Patients
- A holistic view of how to work with patients virtually...
- The concordance conundrum: the value of improving patient experience
- This is the first in a series of articles where we explore how the current climate presents companies with a multitude of opportunities to improve communication between healthcare organisations and...
Quick links
Infographics
